78 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
3 Jun 24
Current report (foreign)
4:05pm
autoleucel; cilta-cel) with or without lenalidomide maintenance.1 These data were presented as an oral presentation at the 2024 American Society … Meeting – American Society of Clinical Oncology. June 2024.
2 Costa, L., et al. Ciltacabtagene autoleucel vs standard of care in patients
6-K
EX-99.1
LEGN
Legend Biotech Corp
23 May 24
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
5:00pm
will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2024 European Hematology Association’s (EHA) Hybrid Congress.
Data … Cancer Society. ”What is Multiple Myeloma?”. Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/what-is-multiple-myeloma.html
6-K
LEGN
Legend Biotech Corp
23 May 24
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
5:00pm
autoleucel; cilta-cel) for patients with multiple myeloma will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
6-K
EX-99.1
LEGN
Legend Biotech Corp
22 Apr 24
Current report (foreign)
1:06pm
-Refractory Multiple Myeloma (CARTITUDE-4). https://www.clinicaltrials.gov/study/NCT04181827. Accessed March 2024.
3 American Cancer Society. ”What … Cancer Society. “Key Statistics About Multiple Myeloma.” Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/key-statistics.html
6-K
EX-99.1
LEGN
Legend Biotech Corp
8 Apr 24
Current report (foreign)
7:03am
Multiple Myeloma (CARTITUDE-4). https://www.clinicaltrials.gov/study/NCT04181827. Accessed March 2024
iii American Cancer Society. ”What is Multiple … Society. “Key Statistics About Multiple Myeloma.” Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/key-statistics.htm
6-K
EX-99.1
1cbqvpl25di pp7y4
15 Mar 24
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARITUDE-4 study
3:18pm
6-K
EX-99.1
x55k7kx
11 Mar 24
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
7:52am
6-K
EX-99.1
jiqvw2
23 Feb 24
Current report (foreign)
7:16am
6-K
EX-99.1
nvvxet2p3 v0qcm99c
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
r1pddjh
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
faypjioe4tq0lmuw4kn0
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.1
r0o6h4zr
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.1
gs0dm2khqij1d4b
6 Jun 23
Legend Biotech Corporation 6-K
4:44pm
6-K
EX-99.1
dbyaj7ptw4pvp1ibrqv
5 Jun 23
Legend Biotech 6-K
11:17am
6-K
EX-99.1
g8fcvi95ai3gb8
25 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
n65 hsmvwpej9i3
18 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
ipv5muj7fpwccc
16 May 23
Legend Biotech Corporation 6-K
8:39am
6-K
spiwtxvvwqgpp03g
16 May 23
Legend Biotech Corporation 6-K
8:39am